The genetic architecture of the etiology of lower extremity peripheral artery disease: current knowledge and future challenges in the era of genomic medicine

HIGHLIGHTS

SUMMARY

2022, 23, 10481 3 of 33 3 of 32 both LEAD diagnosis and surveillance and a powerful marker of generalized atheroscleboth LEAD diagnosis and surveillance and a powerful marker of generalized atherosclerosis rosis and cardiovascular risk. The diagnostic value of ABI for patients with LEAD LEAD is considerably limited in patients with calcified or non-compressible vessels (e_g, is considerably limited in patients with calcified or non-compressible vessels (e_g, in in patients with DM or with end-stage renal disease-ESRD), in whom false elevated ABIs patients with DM or with end-stage . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.